New diabetes clinical trial: Autologous CD6-CAR Treg Cells for Patients With Stage 3 Type 1 Diabetes

Published on: February 08, 2026 at 11:00PM
Conditions: Stage 3 Type 1 Diabetes
Interventions: Drug: AutoCD6-CAR Treg cells
Sponsors: City of Hope Medical Center; National Cancer Institute (NCI)
Not yet recruiting
https://ift.tt/SWLso4q